TITLE

DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy

AUTHOR(S)
Mladenov, Emil; Magin, Simon; Soni, Aashish; Iliakis, George
PUB. DATE
May 2013
SOURCE
Frontiers in Oncology;May2013, Vol. 3, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Radiation therapy plays an important role in the management of a wide range of cancers. Besides innovations in the physical application of radiation dose, radiation therapy is likely to benefit from novel approaches exploiting differences in radiation response between normal and tumor cells. While ionizing radiation induces a variety of DNA lesions, including base damages and single-strand breaks, the DNA double-strand break (DSB) is widely considered as the lesion responsible not only for the aimed cell killing of tumor cells, but also for the general genomic instability that leads to the development of secondary cancers among normal cells. Homologous recombination repair (HRR), non-homologous end-joining (NHEJ), and alternative NHEJ, operating as a backup, are the major pathways utilized by cells for the processing of DSBs. Therefore, their function represents a major mechanism of radiation resistance in tumor cells. HRR is also required to overcome replication stress - a potent contributor to genomic instability that fuels cancer development. HRR and alternative NHEJ show strong cell-cycle dependency and are likely to benefit from radiation therapy mediated redistribution of tumor cells throughout the cell-cycle. Moreover, the synthetic lethality phenotype documented between HRR deficiency and PARP inhibition has opened new avenues for targeted therapies. These observations make HRR a particularly intriguing target for treatments aiming to improve the efficacy of radiation therapy. Here, we briefly describe the major pathways of DSB repair and review their possible contribution to cancer cell radioresistance. Finally, we discuss promising alternatives for targeting DSB repair to improve radiation therapy and cancer treatment.
ACCESSION #
88067161

 

Related Articles

  • DNA Double-Strand Break Repair as determinant of cellular radiosensitivity to killing and target in radiation therapy. Mladenov, Emil; Magin, Simon; Soni, Aashish; Iliakis, George // Frontiers in Oncology;Apr2013, preceding p1 

    Radiation therapy plays an important role in the management of a wide range of cancers. Besides innovations in the physical application of radiation dose, radiation therapy is likely to benefit from novel approaches exploiting differences in radiation response between normal and tumor cells....

  • Radiation-induced bystander effects--implications for cancer. Mothersill, Carmel; Seymour, Colin B. // Nature Reviews Cancer;Feb2004, Vol. 4 Issue 2, p158 

    The term radiation-induced bystander effects describes a situation where cells that have not been directly exposed to ionizing radiation behave as though they have been exposed: they die or they show chromosomal instability and other abnormalities. The bystander cells might be immediately...

  • OPTIMIZING RADIATION THERAPY.  // Warsaw Voice;Sep2015, Issue 9, Special section p14 

    The article offers information on research conducted by researchers of National Center for Nuclear Research (NCBJ) in Warsaw, Poland on methods of optimizing cancer treatment during radiation therapy. Topics discussed include views of the researcher Stanisław Pszona on aim of the research in...

  • Characterization of the combined cellular survival effects of benzoquinone-ansamycins and ionizing radiation. Ochel, Hans-Joachim; Gademann, Günther // Journal of Cancer Research & Clinical Oncology;May2005, Vol. 131 Issue 5, p323 

    Purpose: Benzoquinone-ansamycins were the first compounds characterized with the ability to inhibit the function of heat shock protein 90 and its related family members. We investigated the composite effect of ionizing radiation and of these novel substances on the survival of malignant cells....

  • Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways.  // Radiation Oncology;2011, Vol. 6 Issue 1, p144 

    The article presents a study which aims at analyzing the effects of polyphenol resveratrol (RSV) on the response of prostate cancer (PrCa) cells undergoing ionizing radiation (IR). It explains the methodology of the study in which PrCa was treated with RSV alone and with a combination of RSV...

  • Base excision repair of ionizing radiation-induced DNA damage in G1 and G2 cell cycle phases. Chaudhry, M. Ahmad // Cancer Cell International;2007, Vol. 7, p15 

    Background: Major genomic surveillance mechanisms regulated in response to DNA damage exist at the G1/S and G2/M checkpoints. It is presumed that these delays provide time for the repair of damaged DNA. Cells have developed multiple DNA repair pathways to protect themselves from different types...

  • MiR-122 Induces Radiosensitization in Non-Small Cell Lung Cancer Cell Line. Debin Ma; Hui Jia; Mengmeng Qin; Wenjie Dai; Tao Wang; Erguang Liang; Guofu Dong; Zuojun Wang; Zhiyuan Zhang; Fan Feng // International Journal of Molecular Sciences;Sep2015, Vol. 16 Issue 9, p22137 

    MiR-122 is a novel tumor suppresser and its expression induces cell cycle arrest, or apoptosis, and inhibits cell proliferation in multiple cancer cells, including non-small cell lung cancer (NSCLC) cells. Radioresistance of cancer cell leads to the major drawback of radiotherapy for NSCLC and...

  • The Proteasome Inhibitor MG-132 Protects Hypoxic SiHa Cervical Carcinoma Cells after Cyclic Hypoxia/Reoxygenation from Ionizing Radiation. Pajonk, Frank; Grumann, Thorsten; McBride, William H. // Neoplasia;Dec2006, Vol. 8 Issue 12, p1037 

    INTRODUCTION: Transient hypoxia and subsequent reoxygenation are common phenomena in solid tumors that greatly influence the outcome of radiation therapy. This study was designed to determine how varying cycles of hypoxia/reoxygenation affect the response of cervical carcinoma cells irradiated...

  • Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes. Gomez-Casal, Roberto; Bhattacharya, Chitralekha; Ganesh, Nandita; Bailey, Lisa; Basse, Per; Gibson, Michael; Epperly, Michael; Levina, Vera // Molecular Cancer;2013, Vol. 12 Issue 1, p1 

    Ionizing radiation (IR) is used for patients diagnosed with unresectable non small cell lung cancer (NSCLC), however radiotherapy remains largely palliative due to radioresistance. Cancer stem cells (CSCs), as well as epithelialmesenchymal transition (EMT), may contribute to drug and radiation...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics